CANCER AID FOR NORTH/EAST (SRI LANKA)
The principal activity of the company continues to be that of promotion of relief for persons suffering from cancer in North and East of Sri Lanka.
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net income surplus of £32,048 for the year ended 30 November 2024, increasing its total unrestricted funds to £133,216. The trustees maintain a reserves policy to hold funds equivalent to twelve months of unrestricted expenditure. The independent examiner confirmed that no matters came to their attention to suggest the accounts were not prepared in accordance with applicable standards.
What the accounts disclose
“It is the policy of the charity to maintain unrestricted funds a at level, which equates to twelve months unrestricted expenditure.” — page 4
Trustees
- Dr PARARASASEKARAN THAYALASEKARANchair
- Dr JAYENDRAN NAMASIVAYAM
- Dr KAMALADEVI ARUNASALAM
- Ghandhimathy Sooriyakumar
- KANAGARASA DIVAHARAN
- MAHESWARAN SRI RAGAVAN
- MR Gridharan Wijayasingam
- MURUGESU THANGARAJAH
- RAMANI VAHEESAN
- SHANTHINI THAYALASEKARAN
- VELUPPILLAI SIVASUNDRAM
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/11/2024 | £59k | £27k |
| 30/11/2023 | £45k | £29k |
| 30/11/2022 | £34k | £46k |
| 30/11/2021 | £30k | £18k |
| 30/11/2020 | £42k | £53k |
Common questions
Is CANCER AID FOR NORTH/EAST (SRI LANKA) financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a net income surplus of £32,048 for the year ended 30 November 2024, increasing its total unrestricted funds to £133,216. The trustees maintain a reserves policy to hold funds equivalent to twelve months of unrestricted expenditure. The independent examiner confirmed that no matters came to their attention to suggest the accounts were not prepared in accordance with applicable standards. Its FY2024 accounts were independently examined.